syndrome	score	normalized_score
INSULINOMA	0.3492066	100.0
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	87.49994988639963
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	79.54546105371433
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	71.92000380290635
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.25	71.59085767565676
HYPERPARATHYROIDISM 2	0.25	71.59085767565676
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.25	71.59085767565676
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	71.59085767565676
DYSTONIA 6, TORSION	0.25	71.59085767565676
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.25	71.59085767565676
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.23448280000000002	67.14729904875797
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.216667	62.0455054400461
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	57.27268614052542
ROMANO-WARD SYNDROME	0.2	57.27268614052542
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	57.27268614052542
TRICHOTHIODYSTROPHY	0.2	57.27268614052542
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.1825396	52.27266609508526
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.175	50.11360037295973
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.175	50.11360037295973
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17287818000000002	49.505988718426295
GRANULOMATOSIS WITH POLYANGIITIS	0.16817076	48.157955777468125
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	47.72733390491475
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.166667	47.72733390491475
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	47.72733390491475
PITYRIASIS RUBRA PILARIS	0.166667	47.72733390491475
HEREDITARY FRUCTOSE INTOLERANCE	0.166667	47.72733390491475
PEMPHIGUS VULGARIS	0.166667	47.72733390491475
PFAPA SYNDROME	0.166667	47.72733390491475
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.1400384	40.101876654106775
SLC35A2-CDG	0.12650376	36.22605071038176
PHENYLKETONURIA	0.125	35.79542883782838
CENTRAL PRECOCIOUS PUBERTY	0.125	35.79542883782838
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	35.79542883782838
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	35.79542883782838
THORACOLARYNGOPELVIC DYSPLASIA	0.125	35.79542883782838
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12142860000000001	34.77271048141702
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.11111099999999999	31.81812714879959
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	31.81812714879959
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.11111099999999999	31.81812714879959
OGDEN SYNDROME	0.11111099999999999	31.81812714879959
HUNTINGTON DISEASE-LIKE 3	0.11111099999999999	31.81812714879959
RENAL AGENESIS, BILATERAL	0.11111099999999999	31.81812714879959
FRAGILE X MENTAL RETARDATION SYNDROME	0.11111099999999999	31.81812714879959
SANDIFER SYNDROME	0.11111099999999999	31.81812714879959
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.11111099999999999	31.81812714879959
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.11111099999999999	31.81812714879959
EPISODIC ATAXIA TYPE 4	0.11111099999999999	31.81812714879959
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.11111099999999999	31.81812714879959
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.11111099999999999	31.81812714879959
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.1055556	30.22726374587422
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	25.78370511897542
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0844828	24.1927844433639
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0844828	24.1927844433639
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0844828	24.1927844433639
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0844828	24.1927844433639
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0844828	24.1927844433639
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.07809527000000001	22.36362943884795
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.07317966000000001	20.955978495251813
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.07293236000000002	20.885160818839054
SILVER-RUSSELL SYNDROME	0.07142860000000001	20.45453894628567
TEMPLE SYNDROME	0.07142860000000001	20.45453894628567
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07142860000000001	20.45453894628567
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07142860000000001	20.45453894628567
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	20.45453894628567
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.07142860000000001	20.45453894628567
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07142860000000001	20.45453894628567
WILLIAMS-BEUREN SYNDROME; WBS	0.06327054	18.118368896807794
HEMOCHROMATOSIS, TYPE 1	0.06176678000000001	17.687747024254413
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.06176678000000001	17.687747024254413
SECKEL SYNDROME 10; SCKL10	0.06176678000000001	17.687747024254413
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.05737094	16.428939201034577
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.05705936	16.33971408329625
PYGMY	0.05641948	16.156475851258254
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.05641948	16.156475851258254
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.05641948	16.156475851258254
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.05641948	16.156475851258254
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.056410260000000004	16.153835580427174
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	15.90909221074287
X-LINKED SIDEROBLASTIC ANEMIA	0.055555600000000004	15.90909221074287
ESTROGEN RESISTANCE SYNDROME	0.055555600000000004	15.90909221074287
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	15.90909221074287
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	15.90909221074287
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.055555600000000004	15.90909221074287
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	15.90909221074287
OBESITY DUE TO SIM1 DEFICIENCY	0.055555600000000004	15.90909221074287
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	15.90909221074287
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	15.90909221074287
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.055555600000000004	15.90909221074287
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.055555600000000004	15.90909221074287
HEMOCHROMATOSIS, TYPE 4; HFE4	0.055555600000000004	15.90909221074287
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	15.90909221074287
ESTROGEN RESISTANCE; ESTRR	0.055555600000000004	15.90909221074287
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	15.90909221074287
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.055555600000000004	15.90909221074287
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.055555600000000004	15.90909221074287
ANIRIDIA	0.055555600000000004	15.90909221074287
HYPERLIPOPROTEINEMIA, TYPE IV	0.055555600000000004	15.90909221074287
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.055555600000000004	15.90909221074287
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	15.90909221074287
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	15.071765539368387
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	15.071765539368387
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0526316	15.071765539368387
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	15.071765539368387
274210 THYMIC APLASIA WITH FETAL DEATH	0.0526316	15.071765539368387
STEINERT MYOTONIC DYSTROPHY	0.0526316	15.071765539368387
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0526316	15.071765539368387
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	15.071765539368387
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	15.071765539368387
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	15.071765539368387
BIEMOND SYNDROME II	0.0526316	15.071765539368387
MYASTHENIA GRAVIS; MG	0.0526316	15.071765539368387
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.05150376	14.748793407684735
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.05	14.318171535131356
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	14.318171535131356
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.05	14.318171535131356
PENILE AGENESIS	0.05	14.318171535131356
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.05	14.318171535131356
CAUDAL REGRESSION SEQUENCE	0.05	14.318171535131356
FEMORAL-FACIAL SYNDROME	0.05	14.318171535131356
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05	14.318171535131356
MICROFORM HOLOPROSENCEPHALY	0.05	14.318171535131356
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.05	14.318171535131356
ESOPHAGEAL ATRESIA	0.05	14.318171535131356
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.05	14.318171535131356
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05	14.318171535131356
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.05	14.318171535131356
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	14.318171535131356
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	14.318171535131356
FOIX-CHAVANY-MARIE SYNDROME	0.05	14.318171535131356
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	14.318171535131356
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.05	14.318171535131356
ULBRIGHT-HODES SYNDROME	0.05	14.318171535131356
GITELMAN SYNDROME	0.05	14.318171535131356
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.05	14.318171535131356
HYPOPLASTIC LEFT HEART SYNDROME	0.05	14.318171535131356
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044871760000000004	12.849631135264913
ABLEPHARON-MACROSTOMIA SYNDROME	0.043200840000000004	12.37114075163528
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.03922214	11.231786569898738
BECKWITH-WIEDEMANN SYNDROME	0.03922214	11.231786569898738
MAL DE MELEDA	0.0384615	11.013967089969091
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	11.013967089969091
LIP, HAMARTOMATOUS	0.0384615	11.013967089969091
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	11.013967089969091
ACROCEPHALOPOLYDACTYLY	0.0384615	11.013967089969091
BAZEX SYNDROME; BZX	0.0384615	11.013967089969091
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	11.013967089969091
CYCLIC NEUTROPENIA	0.0384615	11.013967089969091
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	11.013967089969091
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	11.013967089969091
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	11.013967089969091
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	11.013967089969091
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	11.013967089969091
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	11.013967089969091
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	11.013967089969091
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	11.013967089969091
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	11.013967089969091
LIP, MEDIAN NODULE OF UPPER	0.0384615	11.013967089969091
JUVENILE ABSENCE EPILEPSY	0.0384615	11.013967089969091
JUVENILE MYOCLONIC EPILEPSY	0.0384615	11.013967089969091
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	11.013967089969091
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0344828	9.874612908232548
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.0344828	9.874612908232548
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0344828	9.874612908232548
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0344828	9.874612908232548
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.0344828	9.874612908232548
BECKWITH-WIEDEMANN SYNDROME	0.0344828	9.874612908232548
HYPOTONIA-CYSTINURIA SYNDROME	0.0344828	9.874612908232548
DILATED CARDIOMYOPATHY WITH ATAXIA	0.0344828	9.874612908232548
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0344828	9.874612908232548
MODY	0.0344828	9.874612908232548
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0344828	9.874612908232548
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.0344828	9.874612908232548
GLYCOGEN STORAGE DISEASE 0, LIVER	0.0344828	9.874612908232548
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.034444470000000005	9.863636597933718
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	8.385167977924816
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	7.954546105371435
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	7.954546105371435
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	7.954546105371435
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	7.954546105371435
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	7.954546105371435
DWARFISM, LEVI TYPE	0.027777800000000002	7.954546105371435
DIMPLES, FACIAL	0.027777800000000002	7.954546105371435
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	7.954546105371435
OROFACIAL CLEFT 3	0.027777800000000002	7.954546105371435
CLEFT CHIN	0.027777800000000002	7.954546105371435
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	7.954546105371435
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	7.954546105371435
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	7.954546105371435
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	7.954546105371435
15Q13.3 MICRODELETION SYNDROME	0.027777800000000002	7.954546105371435
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	7.954546105371435
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	7.954546105371435
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	7.954546105371435
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	7.954546105371435
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	7.954546105371435
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	7.954546105371435
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	7.954546105371435
CYANIDE, INABILITY TO SMELL	0.027777800000000002	7.954546105371435
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	7.954546105371435
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	7.954546105371435
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	7.954546105371435
NASAL BONES, ABSENCE OF	0.027777800000000002	7.954546105371435
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	7.954546105371435
MENKES DISEASE	0.027777800000000002	7.954546105371435
HEMIFACIAL MICROSOMIA	0.023179659999999998	6.6378069601204555
GOLDENHAR SYNDROME	0.021675899999999998	6.2071850875670735
TOWNES-BROCKS SYNDROME	0.021675899999999998	6.2071850875670735
EMANUEL SYNDROME	0.020724439999999997	5.934721737790751
OTOMANDIBULAR SYNDROME	0.01844032	5.280633298454267
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.01844032	5.280633298454267
DUANE RETRACTION SYNDROME	0.01844032	5.280633298454267
BRANCHIOOTIC SYNDROME	0.01844032	5.280633298454267
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.01693656	4.8500114259008855
OCULOAURICULOFRONTONASAL SYNDROME	0.01693656	4.8500114259008855
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01693656	4.8500114259008855
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.01693656	4.8500114259008855
AURICULOCONDYLAR SYNDROME	0.01693656	4.8500114259008855
CHARGE SYNDROME	0.01693656	4.8500114259008855
CRI-DU-CHAT SYNDROME	0.01693656	4.8500114259008855
WILDERVANCK SYNDROME	0.01693656	4.8500114259008855
16P13.11 MICRODELETION SYNDROME	0.016769399999999997	4.802142914824634
HAMAMY SYNDROME; HMMS	0.016769399999999997	4.802142914824634
LAMBERT SYNDROME	0.015265639999999999	4.371521042271252
LAMBERT SYNDROME	0.015265639999999999	4.371521042271252
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.015265639999999999	4.371521042271252
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.015265639999999999	4.371521042271252
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.015265639999999999	4.371521042271252
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.015265639999999999	4.371521042271252
8P INVERTED DUPLICATION/DELETION SYNDROME	0.015265639999999999	4.371521042271252
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.015265639999999999	4.371521042271252
COFFIN-SIRIS SYNDROME 1; CSS1	0.015265639999999999	4.371521042271252
16Q24.3 MICRODELETION SYNDROME	0.015265639999999999	4.371521042271252
TREACHER-COLLINS SYNDROME	0.015265639999999999	4.371521042271252
PETERS PLUS SYNDROME	0.015265639999999999	4.371521042271252
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.015265639999999999	4.371521042271252
OCULOCEREBROCUTANEOUS SYNDROME	0.015265639999999999	4.371521042271252
ISOLATED COMPLEX I DEFICIENCY	0.014381610000000001	4.118367178627209
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.014381610000000001	4.118367178627209
TRISOMY 18-LIKE SYNDROME	0.01431418	4.09905769249493
%608572 BURN-MCKEOWN SYNDROME	0.01431418	4.09905769249493
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01307693	3.7447545378581046
HOLOPROSENCEPHALY	0.01287785	3.687745306073826
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01287785	3.687745306073826
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.01287785	3.687745306073826
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.012653359999999999	3.623459579515393
KABUKI SYNDROME	0.012030059999999999	3.4449692531584453
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012030059999999999	3.4449692531584453
LOWE-KOHN-COHEN SYNDROME	0.012030059999999999	3.4449692531584453
TRISOMY 13	0.012030059999999999	3.4449692531584453
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.012030059999999999	3.4449692531584453
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.012030059999999999	3.4449692531584453
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.012030059999999999	3.4449692531584453
COHEN SYNDROME	0.012030059999999999	3.4449692531584453
TOWNES-BROCKS SYNDROME 1; TBS1	0.012030059999999999	3.4449692531584453
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.012030059999999999	3.4449692531584453
CHROMOSOME 10Q26 DELETION SYNDROME	0.011701900000000001	3.350996229739072
SMITH-KINGSMORE SYNDROME; SKS	0.011406010000000001	3.266264154228472
SIMPSON-GOLABI-BEHMEL SYNDROME	0.011406010000000001	3.266264154228472
MOSAIC TRISOMY 1	0.011149599999999999	3.19283770696201
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.011149599999999999	3.19283770696201
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.011149599999999999	3.19283770696201
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.011149599999999999	3.19283770696201
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.011149599999999999	3.19283770696201
TRISOMY 18P	0.010526299999999999	3.014347380605063
TRISOMY 8P	0.010526299999999999	3.014347380605063
1Q44 MICRODELETION SYNDROME	0.010526299999999999	3.014347380605063
FRONTONASAL DYSPLASIA 1; FND1	0.010526299999999999	3.014347380605063
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.010526299999999999	3.014347380605063
ISOTRETINOIN-LIKE SYNDROME	0.010526299999999999	3.014347380605063
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.010526299999999999	3.014347380605063
MICROPHTHALMIA, SYNDROMIC 4	0.010526299999999999	3.014347380605063
ACITRETIN/ETRETINATE EMBRYOPATHY	0.010526299999999999	3.014347380605063
KAPUR-TORIELLO SYNDROME	0.010526299999999999	3.014347380605063
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.010526299999999999	3.014347380605063
ACROCALLOSAL SYNDROME; ACLS	0.010526299999999999	3.014347380605063
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.010526299999999999	3.014347380605063
FRONTORHINY	0.010526299999999999	3.014347380605063
BRANCHIOGENIC DEAFNESS SYNDROME	0.010526299999999999	3.014347380605063
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.010526299999999999	3.014347380605063
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.010526299999999999	3.014347380605063
KAPUR-TORIELLO SYNDROME	0.010526299999999999	3.014347380605063
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.010526299999999999	3.014347380605063
BOR SYNDROME	0.010526299999999999	3.014347380605063
FRONTONASAL DYSPLASIA	0.010526299999999999	3.014347380605063
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.010526299999999999	3.014347380605063
PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1	0.010526299999999999	3.014347380605063
14Q22Q23 MICRODELETION SYNDROME	0.010526299999999999	3.014347380605063
TETRAPLOIDY	0.010526299999999999	3.014347380605063
BRANCHIOOTORENAL SYNDROME 1	0.010526299999999999	3.014347380605063
EMANUEL SYNDROME	0.010526299999999999	3.014347380605063
CRANIOTELENCEPHALIC DYSPLASIA	0.010526299999999999	3.014347380605063
CAT-EYE SYNDROME (TYPE I)	0.010526299999999999	3.014347380605063
CAT-EYE SYNDROME	0.010526299999999999	3.014347380605063
DEXTROCARDIA	0.010526299999999999	3.014347380605063
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.010526299999999999	3.014347380605063
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.010526299999999999	3.014347380605063
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.010526299999999999	3.014347380605063
MICROPHTHALMIA, LENZ TYPE	0.010526299999999999	3.014347380605063
MONOSOMY 5P	0.010526299999999999	3.014347380605063
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.010526299999999999	3.014347380605063
FRONTOFACIONASAL DYSPLASIA	0.010526299999999999	3.014347380605063
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010526299999999999	3.014347380605063
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.010526299999999999	3.014347380605063
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.010526299999999999	3.014347380605063
3C SYNDROME	0.010526299999999999	3.014347380605063
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.010526299999999999	3.014347380605063
PROXIMAL SPINAL MUSCULAR ATROPHY	0.010526299999999999	3.014347380605063
BARAITSER-WINTER SYNDROME 1; BRWS1	0.01003098	2.872505846109438
ASPARTYLGLUCOSAMINURIA; AGU	0.00852722	2.4418839735560556
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00852722	2.4418839735560556
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00852722	2.4418839735560556
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.008170430000000001	2.3397123651156657
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.008170430000000001	2.3397123651156657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.008170430000000001	2.3397123651156657
SHEEHAN SYNDROME	0.008170430000000001	2.3397123651156657
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.008170430000000001	2.3397123651156657
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.008170430000000001	2.3397123651156657
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.008170430000000001	2.3397123651156657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.008170430000000001	2.3397123651156657
CADASIL	0.008170430000000001	2.3397123651156657
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.008170430000000001	2.3397123651156657
DEAFNESS-CRANIOFACIAL SYNDROME	0.00791402	2.266285917849205
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00791402	2.266285917849205
CRANIOFRONTONASAL DYSPLASIA	0.00791402	2.266285917849205
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00791402	2.266285917849205
APERT SYNDROME	0.00791402	2.266285917849205
DUANE-RADIAL RAY SYNDROME; DRRS	0.00791402	2.266285917849205
CONGENITAL HYDROCEPHALUS	0.00791402	2.266285917849205
15Q26 OVERGROWTH SYNDROME	0.00791402	2.266285917849205
SAETHRE-CHOTZEN SYNDROME	0.00791402	2.266285917849205
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00791402	2.266285917849205
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00771494	2.2092766860649258
KEARNS-SAYRE SYNDROME; KSS	0.00771494	2.2092766860649258
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00771494	2.2092766860649258
RENPENNING SYNDROME	0.00771494	2.2092766860649258
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00771494	2.2092766860649258
WOLFRAM SYNDROME 2; WFS2	0.00771494	2.2092766860649258
RAMON SYNDROME	0.00771494	2.2092766860649258
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00771494	2.2092766860649258
NORRIE DISEASE	0.00771494	2.2092766860649258
NEUTRAL LIPID STORAGE MYOPATHY	0.00771494	2.2092766860649258
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00771494	2.2092766860649258
JOHANSON-BLIZZARD SYNDROME	0.00771494	2.2092766860649258
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00771494	2.2092766860649258
SHORT SYNDROME	0.00771494	2.2092766860649258
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00771494	2.2092766860649258
WOODHOUSE-SAKATI SYNDROME	0.00771494	2.2092766860649258
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00771494	2.2092766860649258
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00771494	2.2092766860649258
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00771494	2.2092766860649258
JOHANSON-BLIZZARD SYNDROME; JBS	0.00771494	2.2092766860649258
WOLFRAM SYNDROME	0.00771494	2.2092766860649258
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00771494	2.2092766860649258
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00771494	2.2092766860649258
HISTIOCYTOID CARDIOMYOPATHY	0.00666667	1.9090904925622827
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	1.9090904925622827
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.00666667	1.9090904925622827
TENORIO SYNDROME; TNORS	0.00666667	1.9090904925622827
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	1.9090904925622827
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00666667	1.9090904925622827
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IXA	0.00666667	1.9090904925622827
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00666667	1.9090904925622827
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00666667	1.9090904925622827
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00666667	1.9090904925622827
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00666667	1.9090904925622827
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	1.9090904925622827
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	1.9090904925622827
MEHMO SYNDROME; MEHMO	0.00666667	1.9090904925622827
2P21 MICRODELETION SYNDROME	0.00666667	1.9090904925622827
PROPIONIC ACIDEMIA	0.00666667	1.9090904925622827
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00666667	1.9090904925622827
TIMOTHY SYNDROME; TS	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00666667	1.9090904925622827
GLYCEROL KINASE DEFICIENCY; GKD	0.00666667	1.9090904925622827
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	1.9090904925622827
WOLCOTT-RALLISON SYNDROME	0.00666667	1.9090904925622827
INFANTILE LIVER FAILURE SYNDROME 2	0.00666667	1.9090904925622827
OCULODENTODIGITAL DYSPLASIA	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00666667	1.9090904925622827
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00666667	1.9090904925622827
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00666667	1.9090904925622827
ENDOCARDIAL FIBROELASTOSIS	0.00666667	1.9090904925622827
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	1.9090904925622827
CONGENITAL DISORDER OF GLYCOSYLATION	0.00666667	1.9090904925622827
SHASHI-PENA SYNDROME; SHAPNS	0.00666667	1.9090904925622827
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	1.9090904925622827
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00666667	1.9090904925622827
MIRAGE SYNDROME; MIRAGE	0.00666667	1.9090904925622827
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00666667	1.9090904925622827
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00666667	1.9090904925622827
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00666667	1.9090904925622827
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.00666667	1.9090904925622827
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00666667	1.9090904925622827
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00666667	1.9090904925622827
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00666667	1.9090904925622827
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00666667	1.9090904925622827
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
RIBOFLAVIN DEFICIENCY	0.00666667	1.9090904925622827
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.00666667	1.9090904925622827
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00666667	1.9090904925622827
BETA-KETOTHIOLASE DEFICIENCY	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00666667	1.9090904925622827
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00666667	1.9090904925622827
SOTOS SYNDROME	0.00666667	1.9090904925622827
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00666667	1.9090904925622827
ADDISON DISEASE	0.00666667	1.9090904925622827
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
LEPRECHAUNISM	0.00666667	1.9090904925622827
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00666667	1.9090904925622827
NAVAJO NEUROHEPATOPATHY	0.00666667	1.9090904925622827
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
HEMOCHROMATOSIS, NEONATAL	0.00666667	1.9090904925622827
COG8-CDG	0.00666667	1.9090904925622827
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00666667	1.9090904925622827
PITUITARY STALK INTERRUPTION SYNDROME	0.00666667	1.9090904925622827
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.00666667	1.9090904925622827
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	1.9090904925622827
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.00666667	1.9090904925622827
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00666667	1.9090904925622827
ACUTE ADRENAL INSUFFICIENCY	0.00666667	1.9090904925622827
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00666667	1.9090904925622827
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00666667	1.9090904925622827
PROPIONIC ACIDEMIA	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00666667	1.9090904925622827
MAPLE SYRUP URINE DISEASE; MSUD	0.00666667	1.9090904925622827
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	1.9090904925622827
VISCERAL STEATOSIS, CONGENITAL	0.00666667	1.9090904925622827
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00666667	1.9090904925622827
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	1.9090904925622827
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.00666667	1.9090904925622827
GALACTOSEMIA	0.00666667	1.9090904925622827
HEPATOCELLULAR CARCINOMA	0.00666667	1.9090904925622827
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	1.9090904925622827
FRUCTOSE AND GALACTOSE INTOLERANCE	0.00666667	1.9090904925622827
PANHYPOPITUITARISM	0.00666667	1.9090904925622827
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	1.9090904925622827
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00666667	1.9090904925622827
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	1.9090904925622827
GLUTARIC ACIDEMIA I; GA1	0.00666667	1.9090904925622827
MPI-CDG	0.00666667	1.9090904925622827
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00666667	1.9090904925622827
CLASSIC GALACTOSEMIA	0.00666667	1.9090904925622827
LARON SYNDROME	0.00666667	1.9090904925622827
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00666667	1.9090904925622827
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	1.9090904925622827
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00666667	1.9090904925622827
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00666667	1.9090904925622827
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00666667	1.9090904925622827
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE VI	0.00666667	1.9090904925622827
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00666667	1.9090904925622827
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	1.9090904925622827
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00666667	1.9090904925622827
HOLOPROSENCEPHALY 1; HPE1	0.00666667	1.9090904925622827
NEONATAL HEMOCHROMATOSIS	0.00666667	1.9090904925622827
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00666667	1.9090904925622827
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00666667	1.9090904925622827
HYPOADRENOCORTICISM, FAMILIAL	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	1.9090904925622827
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00666667	1.9090904925622827
PYRUVATE CARBOXYLASE DEFICIENCY	0.00666667	1.9090904925622827
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00666667	1.9090904925622827
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00666667	1.9090904925622827
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IA	0.00666667	1.9090904925622827
MENKES DISEASE	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IB	0.00666667	1.9090904925622827
COSTELLO SYNDROME; CSTLO	0.00666667	1.9090904925622827
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	1.9090904925622827
PITUITARY APOPLEXY	0.00666667	1.9090904925622827
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00641026	1.835664045295822
ISOLATED HEMIHYPERPLASIA	0.00641026	1.835664045295822
PSEUDOAMINOPTERIN SYNDROME	0.00641026	1.835664045295822
POLYCYSTIC KIDNEY DISEASE 2	0.00641026	1.835664045295822
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00641026	1.835664045295822
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00641026	1.835664045295822
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00641026	1.835664045295822
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.00641026	1.835664045295822
WITTEVEEN-KOLK SYNDROME	0.00641026	1.835664045295822
GRANT SYNDROME	0.00641026	1.835664045295822
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00641026	1.835664045295822
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00641026	1.835664045295822
FOCAL DERMAL HYPOPLASIA	0.00641026	1.835664045295822
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00641026	1.835664045295822
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.00641026	1.835664045295822
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00641026	1.835664045295822
SPINOCEREBELLAR ATAXIA TYPE 34	0.00641026	1.835664045295822
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00641026	1.835664045295822
CLAPO SYNDROME	0.00641026	1.835664045295822
BENCZE SYNDROME	0.00641026	1.835664045295822
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00641026	1.835664045295822
WYBURN-MASON SYNDROME	0.00641026	1.835664045295822
CAFFEY DISEASE	0.00641026	1.835664045295822
TORTICOLLIS	0.00641026	1.835664045295822
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00641026	1.835664045295822
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00641026	1.835664045295822
CHARGE SYNDROME	0.00641026	1.835664045295822
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00641026	1.835664045295822
CURRY-JONES SYNDROME	0.00641026	1.835664045295822
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00641026	1.835664045295822
PROTEUS SYNDROME	0.00641026	1.835664045295822
CRANIOFACIAL DYSSYNOSTOSIS	0.00641026	1.835664045295822
PFEIFFER SYNDROME	0.00641026	1.835664045295822
ELSAHY-WATERS SYNDROME; ESWS	0.00641026	1.835664045295822
SECKEL SYNDROME 1; SCKL1	0.00641026	1.835664045295822
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00641026	1.835664045295822
FANCONI ANEMIA	0.00641026	1.835664045295822
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.00641026	1.835664045295822
DISTAL TRISOMY 15Q	0.00641026	1.835664045295822
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00641026	1.835664045295822
CURRY-JONES SYNDROME	0.00641026	1.835664045295822
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00641026	1.835664045295822
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00641026	1.835664045295822
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00641026	1.835664045295822
OCULOCEREBROCUTANEOUS SYNDROME	0.00641026	1.835664045295822
48,XXYY SYNDROME	0.00641026	1.835664045295822
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00641026	1.835664045295822
FEINGOLD SYNDROME 1; FGLDS1	0.00641026	1.835664045295822
DUBOWITZ SYNDROME	0.00641026	1.835664045295822
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00641026	1.835664045295822
HYPERTRICHOSIS CUBITI	0.00641026	1.835664045295822
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00641026	1.835664045295822
GABRIELE-DE VRIES SYNDROME	0.00641026	1.835664045295822
TEMTAMY SYNDROME	0.00641026	1.835664045295822
PROGRESSIVE HEMIFACIAL ATROPHY	0.00641026	1.835664045295822
CORNELIA DE LANGE SYNDROME 3	0.00641026	1.835664045295822
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00641026	1.835664045295822
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00641026	1.835664045295822
OCULOECTODERMAL SYNDROME; OES	0.00641026	1.835664045295822
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.00641026	1.835664045295822
KLEEFSTRA SYNDROME	0.00641026	1.835664045295822
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00641026	1.835664045295822
TETRASOMY 18P	0.00641026	1.835664045295822
TRIOPIA	0.00641026	1.835664045295822
LAMB-SHAFFER SYNDROME	0.00641026	1.835664045295822
DEAFNESS-CRANIOFACIAL SYNDROME	0.00641026	1.835664045295822
LINEAR NEVUS SEBACEUS SYNDROME	0.00641026	1.835664045295822
WILDERVANCK SYNDROME	0.00641026	1.835664045295822
ISOLATED PLAGIOCEPHALY	0.00641026	1.835664045295822
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00641026	1.835664045295822
2Q32Q33 MICRODELETION SYNDROME	0.00641026	1.835664045295822
2Q31.1 MICRODELETION SYNDROME	0.00641026	1.835664045295822
AICARDI SYNDROME; AIC	0.00641026	1.835664045295822
CRANIOFRONTONASAL SYNDROME; CFNS	0.00641026	1.835664045295822
MELNICK-NEEDLES SYNDROME	0.00641026	1.835664045295822
FAMILIAL LAMBDOID SYNOSTOSIS	0.00641026	1.835664045295822
MULTIPLE SYNOSTOSES SYNDROME	0.00641026	1.835664045295822
OROFACIODIGITAL SYNDROME TYPE 1	0.00641026	1.835664045295822
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00641026	1.835664045295822
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00641026	1.835664045295822
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00641026	1.835664045295822
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00641026	1.835664045295822
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00641026	1.835664045295822
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00641026	1.835664045295822
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00641026	1.835664045295822
48,XXXY SYNDROME	0.00641026	1.835664045295822
WIEDEMANN-STEINER SYNDROME	0.00641026	1.835664045295822
3Q29 MICRODELETION SYNDROME	0.00641026	1.835664045295822
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00641026	1.835664045295822
OTOFACIOCERVICAL SYNDROME	0.00641026	1.835664045295822
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00641026	1.835664045295822
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.00641026	1.835664045295822
DISTAL MONOSOMY 10Q	0.00641026	1.835664045295822
FOCAL DERMAL HYPOPLASIA; FDH	0.00641026	1.835664045295822
VELO-FACIAL-SKELETAL SYNDROME	0.00641026	1.835664045295822
GORDON SYNDROME	0.00641026	1.835664045295822
SCLEROSTEOSIS 2; SOST2	0.00641026	1.835664045295822
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00641026	1.835664045295822
OROFACIODIGITAL SYNDROME I; OFD1	0.00641026	1.835664045295822
JOHNSON NEUROECTODERMAL SYNDROME	0.00641026	1.835664045295822
CHROMOSOME 17Q12 DELETION SYNDROME	0.00641026	1.835664045295822
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00641026	1.835664045295822
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00641026	1.835664045295822
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00641026	1.835664045295822
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00641026	1.835664045295822
ZTTK SYNDROME; ZTTKS	0.00641026	1.835664045295822
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00641026	1.835664045295822
HEMIFACIAL HYPERPLASIA	0.00641026	1.835664045295822
JACOBSEN SYNDROME	0.00641026	1.835664045295822
MALAN OVERGROWTH SYNDROME	0.00641026	1.835664045295822
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00641026	1.835664045295822
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00641026	1.835664045295822
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00641026	1.835664045295822
15Q24 MICRODELETION SYNDROME	0.00641026	1.835664045295822
ISOLATED KLIPPEL-FEIL SYNDROME	0.00641026	1.835664045295822
SCHEIE SYNDROME	0.0062431	1.787795534219571
FOUNTAIN SYNDROME	0.0062431	1.787795534219571
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0062431	1.787795534219571
SMITH-LEMLI-OPITZ SYNDROME	0.0062431	1.787795534219571
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0062431	1.787795534219571
FG SYNDROME TYPE 1	0.0062431	1.787795534219571
BILATERAL POLYMICROGYRIA	0.0062431	1.787795534219571
MONOSOMY 18Q	0.0062431	1.787795534219571
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0062431	1.787795534219571
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0062431	1.787795534219571
ZIMMERMANN-LABAND SYNDROME	0.0062431	1.787795534219571
WILLIAMS SYNDROME	0.0062431	1.787795534219571
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0062431	1.787795534219571
COFFIN-LOWRY SYNDROME	0.0062431	1.787795534219571
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.0062431	1.787795534219571
PETTIGREW SYNDROME	0.0062431	1.787795534219571
VIPOMA	0.00621118	1.7786548135115432
ACROMEGALY	0.00621118	1.7786548135115432
RCAD (RENAL CYSTS AND DIABETES)	0.00621118	1.7786548135115432
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00621118	1.7786548135115432
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00621118	1.7786548135115432
GLUCAGONOMA	0.00621118	1.7786548135115432
NEUROTROPHIC KERATOPATHY	0.00621118	1.7786548135115432
BARDET-BIEDL SYNDROME 1; BBS1	0.00621118	1.7786548135115432
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00621118	1.7786548135115432
HYPERLIPOPROTEINEMIA, TYPE V	0.00621118	1.7786548135115432
12Q14 MICRODELETION SYNDROME	0.00621118	1.7786548135115432
ACTH-DEPENDENT CUSHING SYNDROME	0.00621118	1.7786548135115432
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00621118	1.7786548135115432
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00621118	1.7786548135115432
PRADER-WILLI SYNDROME	0.00621118	1.7786548135115432
SOMATOSTATINOMA	0.00621118	1.7786548135115432
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00621118	1.7786548135115432
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00621118	1.7786548135115432
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.00621118	1.7786548135115432
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00621118	1.7786548135115432
CUSHING DISEASE	0.00621118	1.7786548135115432
ACTH-INDEPENDENT CUSHING SYNDROME	0.00621118	1.7786548135115432
FRIEDREICH ATAXIA	0.00621118	1.7786548135115432
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00621118	1.7786548135115432
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00621118	1.7786548135115432
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00621118	1.7786548135115432
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00621118	1.7786548135115432
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.00621118	1.7786548135115432
DIABETES MELLITUS, INSULIN-DEPENDENT, 2	0.00621118	1.7786548135115432
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00621118	1.7786548135115432
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00621118	1.7786548135115432
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00621118	1.7786548135115432
MEHMO SYNDROME	0.00621118	1.7786548135115432
167755 PANCREAS, DORSAL, AGENESIS OF	0.00621118	1.7786548135115432
PANCREATITIS, HEREDITARY	0.00621118	1.7786548135115432
AFRICAN IRON OVERLOAD	0.00621118	1.7786548135115432
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00621118	1.7786548135115432
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00621118	1.7786548135115432
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.00621118	1.7786548135115432
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00621118	1.7786548135115432
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00621118	1.7786548135115432
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.00621118	1.7786548135115432
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.00621118	1.7786548135115432
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14	0.00621118	1.7786548135115432
ATAXIA WITH VITAMIN E DEFICIENCY	0.00621118	1.7786548135115432
HEMOCHROMATOSIS TYPE 2	0.00621118	1.7786548135115432
STIFF-PERSON SYNDROME; SPS	0.00621118	1.7786548135115432
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00621118	1.7786548135115432
FAMILIAL PANCREATIC CARCINOMA	0.00621118	1.7786548135115432
H SYNDROME	0.00621118	1.7786548135115432
BARDET-BIEDL SYNDROME 2	0.00621118	1.7786548135115432
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00621118	1.7786548135115432
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.00621118	1.7786548135115432
DYSTROPHIA MYOTONICA 2	0.00621118	1.7786548135115432
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00621118	1.7786548135115432
BETA-THALASSEMIA MAJOR	0.00621118	1.7786548135115432
BETA-THALASSEMIA INTERMEDIA	0.00621118	1.7786548135115432
DYSBETALIPOPROTEINEMIA	0.00621118	1.7786548135115432
WOLFRAM-LIKE SYNDROME	0.00621118	1.7786548135115432
DYSKERATOSIS CONGENITA	0.00621118	1.7786548135115432
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00621118	1.7786548135115432
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00621118	1.7786548135115432
AICARDI-GOUTIÈRES SYNDROME	0.00621118	1.7786548135115432
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00621118	1.7786548135115432
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00621118	1.7786548135115432
ACERULOPLASMINEMIA	0.00621118	1.7786548135115432
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00621118	1.7786548135115432
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.00621118	1.7786548135115432
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00621118	1.7786548135115432
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00621118	1.7786548135115432
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00621118	1.7786548135115432
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.00621118	1.7786548135115432
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00621118	1.7786548135115432
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.00621118	1.7786548135115432
DIABETES MELLITUS, INSULIN-DEPENDENT, 10	0.00621118	1.7786548135115432
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00621118	1.7786548135115432
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00621118	1.7786548135115432
DIABETES MELLITUS, INSULIN-DEPENDENT, 6	0.00621118	1.7786548135115432
ACERULOPLASMINEMIA	0.00621118	1.7786548135115432
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.00621118	1.7786548135115432
EPIDERMOLYSIS BULLOSA ACQUISITA	0.00621118	1.7786548135115432
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00621118	1.7786548135115432
%601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15;;INSULIN-DEPENDENT DIABETES MELLITUS 15	0.00621118	1.7786548135115432
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00621118	1.7786548135115432
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00621118	1.7786548135115432
GOOD SYNDROME	0.00621118	1.7786548135115432
BARDET-BIEDL SYNDROME 6; BBS6	0.00621118	1.7786548135115432
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00621118	1.7786548135115432
WERNER SYNDROME; WRN	0.00621118	1.7786548135115432
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00621118	1.7786548135115432
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00621118	1.7786548135115432
PAROXYSMAL HEMICRANIA	0.00621118	1.7786548135115432
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00621118	1.7786548135115432
HEREDITARY CHRONIC PANCREATITIS	0.00621118	1.7786548135115432
POEMS SYNDROME	0.00621118	1.7786548135115432
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00621118	1.7786548135115432
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00621118	1.7786548135115432
ADRENOCORTICAL CARCINOMA	0.00621118	1.7786548135115432
POLAND SYNDROME	0.00621118	1.7786548135115432
SPLENOPORTAL VASCULAR ANOMALIES	0.00621118	1.7786548135115432
BULLOUS PEMPHIGOID	0.00621118	1.7786548135115432
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00621118	1.7786548135115432
ALEXANDER DISEASE	0.00621118	1.7786548135115432
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.00621118	1.7786548135115432
SOMATOMAMMOTROPINOMA	0.00621118	1.7786548135115432
ERYTHROKERATODERMIA VARIABILIS	0.00621118	1.7786548135115432
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00621118	1.7786548135115432
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00621118	1.7786548135115432
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00621118	1.7786548135115432
17Q12 MICRODELETION SYNDROME	0.00621118	1.7786548135115432
CRANIAL NERVES, RECURRENT PARESIS OF	0.00621118	1.7786548135115432
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00621118	1.7786548135115432
PREAXIAL HALLUCAL POLYDACTYLY	0.00621118	1.7786548135115432
PRIMROSE SYNDROME; PRIMS	0.00621118	1.7786548135115432
CUSHING SYNDROME	0.00621118	1.7786548135115432
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00621118	1.7786548135115432
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00621118	1.7786548135115432
PERIPARTUM CARDIOMYOPATHY	0.00621118	1.7786548135115432
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00529164	1.5153321844432495
NEONATAL ADRENOLEUKODYSTROPHY	0.00529164	1.5153321844432495
HYPERLEUCINE-ISOLEUCINEMIA	0.00529164	1.5153321844432495
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00529164	1.5153321844432495
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00529164	1.5153321844432495
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00529164	1.5153321844432495
REFSUM DISEASE	0.00529164	1.5153321844432495
16P12.1P12.3 TRIPLICATION SYNDROME	0.00473934	1.3571736616661885
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00473934	1.3571736616661885
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00473934	1.3571736616661885
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00473934	1.3571736616661885
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.00473934	1.3571736616661885
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00473934	1.3571736616661885
TRISOMY 17P	0.00473934	1.3571736616661885
PMM2-CDG	0.00473934	1.3571736616661885
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00473934	1.3571736616661885
TRIPLOIDY	0.00473934	1.3571736616661885
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00473934	1.3571736616661885
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00473934	1.3571736616661885
DISTAL TRISOMY 17Q	0.00473934	1.3571736616661885
COFFIN-SIRIS SYNDROME 5	0.00473934	1.3571736616661885
SCHINZEL-GIEDION SYNDROME	0.00473934	1.3571736616661885
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00473934	1.3571736616661885
AICA-RIBOSIDURIA	0.00473934	1.3571736616661885
MOSAIC TRISOMY 14	0.00473934	1.3571736616661885
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00473934	1.3571736616661885
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00473934	1.3571736616661885
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00473934	1.3571736616661885
PITT-HOPKINS SYNDROME	0.00473934	1.3571736616661885
ANGELMAN SYNDROME	0.00473934	1.3571736616661885
1P21.3 MICRODELETION SYNDROME	0.00473934	1.3571736616661885
COFFIN-SIRIS SYNDROME	0.00473934	1.3571736616661885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00473934	1.3571736616661885
FRANK-TER HAAR SYNDROME	0.00473934	1.3571736616661885
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00473934	1.3571736616661885
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00473934	1.3571736616661885
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00473934	1.3571736616661885
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00473934	1.3571736616661885
DISTAL MONOSOMY 7Q36	0.00473934	1.3571736616661885
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.00473934	1.3571736616661885
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00473934	1.3571736616661885
ATYPICAL RETT SYNDROME	0.00473934	1.3571736616661885
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00473934	1.3571736616661885
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00473934	1.3571736616661885
2Q23.1 MICRODUPLICATION SYNDROME	0.00473934	1.3571736616661885
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00473934	1.3571736616661885
DUPLICATION OF THE PITUITARY GLAND	0.00473934	1.3571736616661885
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00473934	1.3571736616661885
NAGER SYNDROME	0.00473934	1.3571736616661885
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00473934	1.3571736616661885
HALL-RIGGS SYNDROME	0.00473934	1.3571736616661885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00473934	1.3571736616661885
COFFIN-SIRIS SYNDROME 10; CSS10	0.00473934	1.3571736616661885
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.00473934	1.3571736616661885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00473934	1.3571736616661885
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00473934	1.3571736616661885
19Q13.11 MICRODELETION SYNDROME	0.00473934	1.3571736616661885
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.00473934	1.3571736616661885
VERVERI-BRADY SYNDROME; VERBRAS	0.00473934	1.3571736616661885
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00473934	1.3571736616661885
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00473934	1.3571736616661885
FRYNS SYNDROME	0.00473934	1.3571736616661885
CEREBROFACIOTHORACIC DYSPLASIA	0.00473934	1.3571736616661885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.00473934	1.3571736616661885
FRYNS-SMEETS-THIRY SYNDROME	0.00473934	1.3571736616661885
FLOATING-HARBOR SYNDROME	0.00473934	1.3571736616661885
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00473934	1.3571736616661885
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00473934	1.3571736616661885
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00473934	1.3571736616661885
FETAL HYDANTOIN SYNDROME	0.00473934	1.3571736616661885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00473934	1.3571736616661885
17P11.2 MICRODUPLICATION SYNDROME	0.00473934	1.3571736616661885
ACROMELIC FRONTONASAL DYSPLASIA	0.00473934	1.3571736616661885
DUBOWITZ SYNDROME	0.00473934	1.3571736616661885
BARBER-SAY SYNDROME	0.00473934	1.3571736616661885
SSR4-CDG	0.00473934	1.3571736616661885
SMITH-FINEMAN-MYERS SYNDROME	0.00473934	1.3571736616661885
CHUDLEY-LOWRY-HOAR SYNDROME	0.00473934	1.3571736616661885
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00473934	1.3571736616661885
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00473934	1.3571736616661885
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00473934	1.3571736616661885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00473934	1.3571736616661885
ABLEPHARON MACROSTOMIA SYNDROME	0.00473934	1.3571736616661885
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00473934	1.3571736616661885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00473934	1.3571736616661885
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00473934	1.3571736616661885
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00473934	1.3571736616661885
TEMPLE-BARAITSER SYNDROME	0.00473934	1.3571736616661885
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.00473934	1.3571736616661885
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00473934	1.3571736616661885
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00473934	1.3571736616661885
COFFIN-SIRIS SYNDROME 7; CSS7	0.00473934	1.3571736616661885
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00473934	1.3571736616661885
TRANSALDOLASE DEFICIENCY	0.00473934	1.3571736616661885
FRYNS SYNDROME; FRNS	0.00473934	1.3571736616661885
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00473934	1.3571736616661885
MORQUIO SYNDROME A	0.00473934	1.3571736616661885
ZUNICH NEUROECTODERMAL SYNDROME	0.00473934	1.3571736616661885
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00473934	1.3571736616661885
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00473934	1.3571736616661885
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.00473934	1.3571736616661885
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00473934	1.3571736616661885
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00473934	1.3571736616661885
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00473934	1.3571736616661885
WARSAW BREAKAGE SYNDROME; WABS	0.00473934	1.3571736616661885
COFFIN-SIRIS SYNDROME 2; CSS2	0.00473934	1.3571736616661885
FLOATING-HARBOR SYNDROME	0.00473934	1.3571736616661885
COFFIN-SIRIS SYNDROME 3; CSS3	0.00473934	1.3571736616661885
COFFIN-SIRIS SYNDROME 4; CSS4	0.00473934	1.3571736616661885
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00473934	1.3571736616661885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00473934	1.3571736616661885
BARBER-SAY SYNDROME; BBRSAY	0.00473934	1.3571736616661885
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00473934	1.3571736616661885
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00473934	1.3571736616661885
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00473934	1.3571736616661885
TEEBI-SHALTOUT SYNDROME; TBSH	0.00473934	1.3571736616661885
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00473934	1.3571736616661885
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00473934	1.3571736616661885
NOONAN SYNDROME 5; NS5	0.00473934	1.3571736616661885
STROMME SYNDROME; STROMS	0.00473934	1.3571736616661885
ARIMA SYNDROME	0.00473934	1.3571736616661885
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00473934	1.3571736616661885
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00473934	1.3571736616661885
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00473934	1.3571736616661885
POTOCKI-LUPSKI SYNDROME	0.00473934	1.3571736616661885
MENTAL RETARDATION, X-LINKED 103	0.00473934	1.3571736616661885
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00473934	1.3571736616661885
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00473934	1.3571736616661885
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00473934	1.3571736616661885
FACIOCARDIOMELIC SYNDROME	0.00473934	1.3571736616661885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.00473934	1.3571736616661885
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00473934	1.3571736616661885
MECKEL SYNDROME, TYPE 1; MKS1	0.00473934	1.3571736616661885
FRANK-TER HAAR SYNDROME; FTHS	0.00473934	1.3571736616661885
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00473934	1.3571736616661885
C SYNDROME	0.00473934	1.3571736616661885
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00473934	1.3571736616661885
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00473934	1.3571736616661885
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00473934	1.3571736616661885
RAINE SYNDROME	0.00473934	1.3571736616661885
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00473934	1.3571736616661885
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.00473934	1.3571736616661885
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00473934	1.3571736616661885
ANGELMAN SYNDROME	0.00473934	1.3571736616661885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00473934	1.3571736616661885
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00473934	1.3571736616661885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00473934	1.3571736616661885
TRICHOHEPATOENTERIC SYNDROME 1	0.00473934	1.3571736616661885
ALAZAMI SYNDROME; ALAZS	0.00473934	1.3571736616661885
HELSMOORTEL-VAN DER AA SYNDROME	0.00473934	1.3571736616661885
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00473934	1.3571736616661885
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00473934	1.3571736616661885
ADENYLOSUCCINASE DEFICIENCY	0.00473934	1.3571736616661885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00473934	1.3571736616661885
COACH SYNDROME	0.00473934	1.3571736616661885
DELETED IN AZOOSPERMIA	0.00378788	1.0847103118898669
DERMATOLEUKODYSTROPHY	0.00378788	1.0847103118898669
XM SYSTEM	0.00378788	1.0847103118898669
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	1.0847103118898669
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	1.0847103118898669
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	1.0847103118898669
HOOFT DISEASE	0.00378788	1.0847103118898669
PREMATURE OVARIAN FAILURE 1	0.00378788	1.0847103118898669
SALLA DISEASE	0.00378788	1.0847103118898669
PITUITARY DWARFISM IV	0.00378788	1.0847103118898669
DERMATITIS, ATOPIC	0.00378788	1.0847103118898669
HYPOASCORBEMIA	0.00378788	1.0847103118898669
GONADOBLASTOMA	0.00378788	1.0847103118898669
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	1.0847103118898669
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	1.0847103118898669
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	1.0847103118898669
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	1.0847103118898669
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	1.0847103118898669
ICHTHYOSIS, X-LINKED	0.00378788	1.0847103118898669
GRANULOMAS, CONGENITAL CEREBRAL	0.00378788	1.0847103118898669
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	1.0847103118898669
46,XX GONADAL DYSGENESIS	0.00378788	1.0847103118898669
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	1.0847103118898669
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	1.0847103118898669
ETHANOLAMINOSIS	0.00378788	1.0847103118898669
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	1.0847103118898669
NEURONAL CEROID LIPOFUSCINOSIS	0.00378788	1.0847103118898669
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	1.0847103118898669
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	1.0847103118898669
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00378788	1.0847103118898669
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00378788	1.0847103118898669
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	1.0847103118898669
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	1.0847103118898669
EPILEPSY-TELANGIECTASIA	0.00378788	1.0847103118898669
FETAL IODINE DEFICIENCY DISORDER	0.00378788	1.0847103118898669
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	1.0847103118898669
SCHIZOPHRENIA 4	0.00378788	1.0847103118898669
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	1.0847103118898669
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	1.0847103118898669
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	1.0847103118898669
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	1.0847103118898669
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	1.0847103118898669
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	1.0847103118898669
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	1.0847103118898669
GLUTATHIONURIA	0.00378788	1.0847103118898669
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	1.0847103118898669
CUTIS LAXA	0.00378788	1.0847103118898669
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	1.0847103118898669
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	1.0847103118898669
ONCOCYTOMA	0.00378788	1.0847103118898669
GAPO SYNDROME; GAPOS	0.00378788	1.0847103118898669
MACROCYTOSIS, FAMILIAL	0.00378788	1.0847103118898669
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	1.0847103118898669
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00378788	1.0847103118898669
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	1.0847103118898669
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00378788	1.0847103118898669
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	1.0847103118898669
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	1.0847103118898669
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	1.0847103118898669
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	1.0847103118898669
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.00378788	1.0847103118898669
SERTOLI CELL-ONLY SYNDROME	0.00378788	1.0847103118898669
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	1.0847103118898669
FINGERPRINT BODY MYOPATHY	0.00378788	1.0847103118898669
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	1.0847103118898669
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	1.0847103118898669
PYRIDOXINE-DEPENDENT EPILEPSY	0.00378788	1.0847103118898669
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.00378788	1.0847103118898669
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	1.0847103118898669
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	1.0847103118898669
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00378788	1.0847103118898669
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	1.0847103118898669
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	1.0847103118898669
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	1.0847103118898669
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	1.0847103118898669
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	1.0847103118898669
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	1.0847103118898669
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	1.0847103118898669
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00378788	1.0847103118898669
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	1.0847103118898669
PENDRED SYNDROME	0.00378788	1.0847103118898669
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	1.0847103118898669
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	1.0847103118898669
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	1.0847103118898669
NEPHROSIALIDOSIS	0.00378788	1.0847103118898669
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	1.0847103118898669
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	1.0847103118898669
LARON SYNDROME	0.00378788	1.0847103118898669
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	1.0847103118898669
PROGESTERONE RESISTANCE	0.00378788	1.0847103118898669
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	1.0847103118898669
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	1.0847103118898669
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	1.0847103118898669
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00378788	1.0847103118898669
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.00378788	1.0847103118898669
OSTEOGENIC SARCOMA	0.00378788	1.0847103118898669
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	1.0847103118898669
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	1.0847103118898669
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	1.0847103118898669
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00378788	1.0847103118898669
REVESZ SYNDROME	0.00378788	1.0847103118898669
OCULORENOCEREBELLAR SYNDROME	0.00378788	1.0847103118898669
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	1.0847103118898669
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	1.0847103118898669
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	1.0847103118898669
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	1.0847103118898669
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	1.0847103118898669
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	1.0847103118898669
MAGNESIUM, ELEVATED RED CELL	0.00378788	1.0847103118898669
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	1.0847103118898669
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	1.0847103118898669
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	1.0847103118898669
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	1.0847103118898669
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00378788	1.0847103118898669
LIPASE DEFICIENCY, COMBINED	0.00378788	1.0847103118898669
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	1.0847103118898669
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	1.0847103118898669
CALVARIAL HYPEROSTOSIS	0.00378788	1.0847103118898669
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	1.0847103118898669
ACETYLATION, SLOW	0.00378788	1.0847103118898669
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00378788	1.0847103118898669
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	1.0847103118898669
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	1.0847103118898669
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	1.0847103118898669
ALAND ISLAND EYE DISEASE	0.00378788	1.0847103118898669
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	1.0847103118898669
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	1.0847103118898669
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	1.0847103118898669
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	1.0847103118898669
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	1.0847103118898669
T-SUBSTANCE ANOMALY	0.00378788	1.0847103118898669
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	1.0847103118898669
MYELOPEROXIDASE DEFICIENCY	0.00378788	1.0847103118898669
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	1.0847103118898669
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	1.0847103118898669
XANTHINURIA, TYPE I	0.00378788	1.0847103118898669
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	1.0847103118898669
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	1.0847103118898669
OSTEOMESOPYKNOSIS	0.00378788	1.0847103118898669
XYLOSIDASE DEFICIENCY	0.00378788	1.0847103118898669
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	1.0847103118898669
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	1.0847103118898669
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00378788	1.0847103118898669
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00378788	1.0847103118898669
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	1.0847103118898669
LYMPHOKINE DEFICIENCY	0.00378788	1.0847103118898669
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	1.0847103118898669
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	1.0847103118898669
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	1.0847103118898669
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	1.0847103118898669
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	1.0847103118898669
WHITE SPONGE NEVUS OF CANNON	0.00378788	1.0847103118898669
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	1.0847103118898669
HEINZ BODY ANEMIAS	0.00378788	1.0847103118898669
GLUTATHIONE REDUCTASE	0.00378788	1.0847103118898669
ZINC, ELEVATED PLASMA	0.00378788	1.0847103118898669
GLOMUVENOUS MALFORMATIONS	0.00378788	1.0847103118898669
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	1.0847103118898669
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	1.0847103118898669
ALKAPTONURIA	0.00378788	1.0847103118898669
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	1.0847103118898669
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	1.0847103118898669
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	1.0847103118898669
FLOOD FACTOR DEFICIENCY	0.00378788	1.0847103118898669
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	1.0847103118898669
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	1.0847103118898669
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	1.0847103118898669
AREDYLD	0.00378788	1.0847103118898669
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	1.0847103118898669
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	1.0847103118898669
LARSEN-LIKE SYNDROME	0.00378788	1.0847103118898669
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	1.0847103118898669
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	1.0847103118898669
HYPERPROGLUCAGONEMIA	0.00378788	1.0847103118898669
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	1.0847103118898669
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	1.0847103118898669
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	1.0847103118898669
OVARIAN CANCER	0.00378788	1.0847103118898669
PACMAN DYSPLASIA	0.00378788	1.0847103118898669
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	1.0847103118898669
PERRY SYNDROME	0.00378788	1.0847103118898669
PARAOXONASE 1	0.00378788	1.0847103118898669
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	1.0847103118898669
APOLIPOPROTEIN(A)	0.00378788	1.0847103118898669
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	1.0847103118898669
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	1.0847103118898669
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	1.0847103118898669
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	1.0847103118898669
MYOPATHY, SPHEROID BODY	0.00378788	1.0847103118898669
SPINAL ARACHNOIDITIS	0.00378788	1.0847103118898669
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	1.0847103118898669
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	1.0847103118898669
KERATOSIS, FAMILIAL ACTINIC	0.00378788	1.0847103118898669
POLYCYSTIC OVARY SYNDROME 1	0.00378788	1.0847103118898669
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	1.0847103118898669
BARTTER SYNDROME	0.00378788	1.0847103118898669
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	1.0847103118898669
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	1.0847103118898669
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	1.0847103118898669
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	1.0847103118898669
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	1.0847103118898669
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	1.0847103118898669
CEPHALIN LIPIDOSIS	0.00378788	1.0847103118898669
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	1.0847103118898669
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	1.0847103118898669
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	1.0847103118898669
MACULAR CORNEAL DYSTROPHY	0.00378788	1.0847103118898669
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	1.0847103118898669
CITRULLINE TRANSPORT DEFECT	0.00378788	1.0847103118898669
BEETURIA	0.00378788	1.0847103118898669
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	1.0847103118898669
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	1.0847103118898669
CARBOXYLESTERASE 1	0.00378788	1.0847103118898669
CATECHOL-O-METHYLTRANSFERASE	0.00378788	1.0847103118898669
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	1.0847103118898669
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	1.0847103118898669
COUMARIN RESISTANCE	0.00378788	1.0847103118898669
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.00378788	1.0847103118898669
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	1.0847103118898669
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	1.0847103118898669
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	1.0847103118898669
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00150376	0.43062187255338247
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00150376	0.43062187255338247
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
BRITTLE CORNEA SYNDROME	0.00150376	0.43062187255338247
ACROCALLOSAL SYNDROME	0.00150376	0.43062187255338247
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00150376	0.43062187255338247
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338247
ADENOHYPOPHYSITIS	0.00150376	0.43062187255338247
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00150376	0.43062187255338247
STICKLER SYNDROME TYPE 1	0.00150376	0.43062187255338247
STICKLER SYNDROME TYPE 2	0.00150376	0.43062187255338247
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.43062187255338247
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00150376	0.43062187255338247
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00150376	0.43062187255338247
STICKLER SYNDROME, TYPE I	0.00150376	0.43062187255338247
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.43062187255338247
HADDAD SYNDROME	0.00150376	0.43062187255338247
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.43062187255338247
NEURAMINIDASE DEFICIENCY	0.00150376	0.43062187255338247
ERMINE PHENOTYPE	0.00150376	0.43062187255338247
TRIPLE A SYNDROME	0.00150376	0.43062187255338247
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00150376	0.43062187255338247
USHER SYNDROME	0.00150376	0.43062187255338247
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00150376	0.43062187255338247
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00150376	0.43062187255338247
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.43062187255338247
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00150376	0.43062187255338247
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.43062187255338247
WAARDENBURG SYNDROME TYPE 2	0.00150376	0.43062187255338247
DEAFNESS, MID-TONE NEURAL	0.00150376	0.43062187255338247
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.43062187255338247
SPINOCEREBELLAR ATAXIA TYPE 37	0.00150376	0.43062187255338247
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00150376	0.43062187255338247
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.43062187255338247
VON HIPPEL-LINDAU DISEASE	0.00150376	0.43062187255338247
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00150376	0.43062187255338247
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.43062187255338247
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.43062187255338247
CORNELIA DE LANGE SYNDROME 1	0.00150376	0.43062187255338247
PAPILLORENAL SYNDROME	0.00150376	0.43062187255338247
WORSTER-DROUGHT SYNDROME	0.00150376	0.43062187255338247
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00150376	0.43062187255338247
DISTAL MONOSOMY 19P13.3	0.00150376	0.43062187255338247
JUBERG-MARSIDI SYNDROME	0.00150376	0.43062187255338247
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.43062187255338247
HURLER-SCHEIE SYNDROME	0.00150376	0.43062187255338247
ACRO-RENAL-OCULAR SYNDROME	0.00150376	0.43062187255338247
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00150376	0.43062187255338247
NASODIGITOACOUSTIC SYNDROME	0.00150376	0.43062187255338247
VOGT-KOYANAGI-HARADA DISEASE	0.00150376	0.43062187255338247
PANHYPOPHYSITIS	0.00150376	0.43062187255338247
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00150376	0.43062187255338247
LEIGH SYNDROME; LS	0.00150376	0.43062187255338247
NAIL-PATELLA SYNDROME	0.00150376	0.43062187255338247
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.43062187255338247
ABRUZZO-ERICKSON SYNDROME	0.00150376	0.43062187255338247
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00150376	0.43062187255338247
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338247
PROXIMAL SYMPHALANGISM	0.00150376	0.43062187255338247
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.43062187255338247
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.43062187255338247
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.43062187255338247
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.43062187255338247
BRANCHIOOCULOFACIAL SYNDROME	0.00150376	0.43062187255338247
THYROCEREBRORENAL SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00150376	0.43062187255338247
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.43062187255338247
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.43062187255338247
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.43062187255338247
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00150376	0.43062187255338247
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.43062187255338247
XERODERMA PIGMENTOSUM	0.00150376	0.43062187255338247
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.43062187255338247
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00150376	0.43062187255338247
ZELLWEGER SYNDROME	0.00150376	0.43062187255338247
COCKAYNE SYNDROME A; CSA	0.00150376	0.43062187255338247
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.43062187255338247
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00150376	0.43062187255338247
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00150376	0.43062187255338247
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00150376	0.43062187255338247
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00150376	0.43062187255338247
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.43062187255338247
NEUROFIBROMATOSIS TYPE 2	0.00150376	0.43062187255338247
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338247
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338247
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.43062187255338247
NOONAN SYNDROME	0.00150376	0.43062187255338247
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00150376	0.43062187255338247
KRABBE DISEASE	0.00150376	0.43062187255338247
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.00150376	0.43062187255338247
CEDNIK SYNDROME	0.00150376	0.43062187255338247
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.43062187255338247
KALLMANN SYNDROME	0.00150376	0.43062187255338247
KID SYNDROME	0.00150376	0.43062187255338247
ERMINE PHENOTYPE	0.00150376	0.43062187255338247
FAMILIAL COLD URTICARIA	0.00150376	0.43062187255338247
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.43062187255338247
X-LINKED AGAMMAGLOBULINEMIA	0.00150376	0.43062187255338247
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.00150376	0.43062187255338247
ALPORT SYNDROME	0.00150376	0.43062187255338247
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.43062187255338247
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00150376	0.43062187255338247
CONGENITAL MYASTHENIC SYNDROME	0.00150376	0.43062187255338247
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.43062187255338247
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.43062187255338247
MERRF	0.00150376	0.43062187255338247
MELAS	0.00150376	0.43062187255338247
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00150376	0.43062187255338247
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00150376	0.43062187255338247
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00150376	0.43062187255338247
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.43062187255338247
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.43062187255338247
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00150376	0.43062187255338247
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00150376	0.43062187255338247
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00150376	0.43062187255338247
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.43062187255338247
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.43062187255338247
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.43062187255338247
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.43062187255338247
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00150376	0.43062187255338247
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00150376	0.43062187255338247
MULTIPLE SULFATASE DEFICIENCY	0.00150376	0.43062187255338247
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00150376	0.43062187255338247
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00150376	0.43062187255338247
PENDRED SYNDROME	0.00150376	0.43062187255338247
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00150376	0.43062187255338247
3P25.3 MICRODELETION SYNDROME	0.00150376	0.43062187255338247
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00150376	0.43062187255338247
STICKLER SYNDROME, TYPE III	0.00150376	0.43062187255338247
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.43062187255338247
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00150376	0.43062187255338247
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00150376	0.43062187255338247
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338247
VICI SYNDROME; VICIS	0.00150376	0.43062187255338247
MARSHALL SYNDROME	0.00150376	0.43062187255338247
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00150376	0.43062187255338247
SIALIDOSIS TYPE 1	0.00150376	0.43062187255338247
RICHARDS-RUNDLE SYNDROME; RRNS	0.00150376	0.43062187255338247
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00150376	0.43062187255338247
STICKLER SYNDROME	0.00150376	0.43062187255338247
SUSAC SYNDROME	0.00150376	0.43062187255338247
HIRSCHSPRUNG DISEASE	0.00150376	0.43062187255338247
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338247
OTODENTAL DYSPLASIA	0.00150376	0.43062187255338247
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00150376	0.43062187255338247
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00150376	0.43062187255338247
SALT-AND-PEPPER SYNDROME	0.00150376	0.43062187255338247
RETINITIS PIGMENTOSA	0.00150376	0.43062187255338247
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00150376	0.43062187255338247
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00150376	0.43062187255338247
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00150376	0.43062187255338247
MICROPHTHALMIA, SYNDROMIC 3	0.00150376	0.43062187255338247
FOUNTAIN SYNDROME	0.00150376	0.43062187255338247
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00150376	0.43062187255338247
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338247
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00150376	0.43062187255338247
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.43062187255338247
GALACTOSE EPIMERASE DEFICIENCY	0.00150376	0.43062187255338247
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00150376	0.43062187255338247
RELAPSING POLYCHONDRITIS	0.00150376	0.43062187255338247
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00150376	0.43062187255338247
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00150376	0.43062187255338247
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.43062187255338247
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00150376	0.43062187255338247
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00150376	0.43062187255338247
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00150376	0.43062187255338247
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00150376	0.43062187255338247
FAMILIAL LONG QT SYNDROME	0.00150376	0.43062187255338247
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.43062187255338247
INFANTILE REFSUM DISEASE	0.00150376	0.43062187255338247
WT LIMB-BLOOD SYNDROME	0.00150376	0.43062187255338247
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.00150376	0.43062187255338247
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00150376	0.43062187255338247
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.43062187255338247
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00150376	0.43062187255338247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.43062187255338247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.43062187255338247
HUNTER-MACDONALD SYNDROME	0.00150376	0.43062187255338247
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.43062187255338247
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00150376	0.43062187255338247
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.43062187255338247
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00150376	0.43062187255338247
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00150376	0.43062187255338247
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338247
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00150376	0.43062187255338247
BRACHYDACTYLY, TYPE B2	0.00150376	0.43062187255338247
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.43062187255338247
BJÖRNSTAD SYNDROME	0.00150376	0.43062187255338247
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00150376	0.43062187255338247
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00150376	0.43062187255338247
AYMÉ-GRIPP SYNDROME	0.00150376	0.43062187255338247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00150376	0.43062187255338247
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00150376	0.43062187255338247
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338247
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.00150376	0.43062187255338247
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00150376	0.43062187255338247
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.43062187255338247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.43062187255338247
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.43062187255338247
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.43062187255338247
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.43062187255338247
NOONAN SYNDROME 11; NS11	0.00150376	0.43062187255338247
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.43062187255338247
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.43062187255338247
FEINGOLD SYNDROME	0.00150376	0.43062187255338247
DYSTONIA, JUVENILE-ONSET	0.00150376	0.43062187255338247
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00150376	0.43062187255338247
CODAS SYNDROME	0.00150376	0.43062187255338247
COFS SYNDROME	0.00150376	0.43062187255338247
COGAN SYNDROME	0.00150376	0.43062187255338247
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00150376	0.43062187255338247
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.43062187255338247
VICI SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.00150376	0.43062187255338247
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00150376	0.43062187255338247
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.43062187255338247
CHROMOSOME 1P36 DELETION SYNDROME	0.00150376	0.43062187255338247
CRANIOMETAPHYSEAL DYSPLASIA	0.00150376	0.43062187255338247
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00150376	0.43062187255338247
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.43062187255338247
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.00150376	0.43062187255338247
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00150376	0.43062187255338247
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00150376	0.43062187255338247
CINCA SYNDROME	0.00150376	0.43062187255338247
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.43062187255338247
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00150376	0.43062187255338247
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.43062187255338247
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00150376	0.43062187255338247
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.43062187255338247
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.43062187255338247
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.43062187255338247
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00150376	0.43062187255338247
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.00150376	0.43062187255338247
MADRAS MOTOR NEURON DISEASE	0.00150376	0.43062187255338247
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.43062187255338247
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.43062187255338247
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00150376	0.43062187255338247
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00150376	0.43062187255338247
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00150376	0.43062187255338247
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00150376	0.43062187255338247
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.43062187255338247
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00150376	0.43062187255338247
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.43062187255338247
DESANTO-SHINAWI SYNDROME	0.00150376	0.43062187255338247
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00150376	0.43062187255338247
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.43062187255338247
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00150376	0.43062187255338247
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 6B	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 5B	0.00150376	0.43062187255338247
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.43062187255338247
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00150376	0.43062187255338247
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00150376	0.43062187255338247
OPTIC ATROPHY 8	0.00150376	0.43062187255338247
CRANIOSYNOSTOSIS 6; CRS6	0.00150376	0.43062187255338247
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00150376	0.43062187255338247
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00150376	0.43062187255338247
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.43062187255338247
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00150376	0.43062187255338247
IMMUNODEFICIENCY 23; IMD23	0.00150376	0.43062187255338247
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00150376	0.43062187255338247
JOUBERT SYNDROME 21	0.00150376	0.43062187255338247
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00150376	0.43062187255338247
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00150376	0.43062187255338247
STEEL SYNDROME; STLS	0.00150376	0.43062187255338247
INFANTILE LIVER FAILURE SYNDROME 1	0.00150376	0.43062187255338247
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00150376	0.43062187255338247
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00150376	0.43062187255338247
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.43062187255338247
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00150376	0.43062187255338247
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.43062187255338247
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.43062187255338247
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00150376	0.43062187255338247
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.43062187255338247
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.43062187255338247
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.43062187255338247
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00150376	0.43062187255338247
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00150376	0.43062187255338247
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.43062187255338247
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.43062187255338247
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00150376	0.43062187255338247
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.43062187255338247
NOONAN SYNDROME 6; NS6	0.00150376	0.43062187255338247
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00150376	0.43062187255338247
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00150376	0.43062187255338247
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 50	0.00150376	0.43062187255338247
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00150376	0.43062187255338247
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00150376	0.43062187255338247
PONTINE TEGMENTAL CAP DYSPLASIA	0.00150376	0.43062187255338247
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00150376	0.43062187255338247
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.43062187255338247
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.00150376	0.43062187255338247
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00150376	0.43062187255338247
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00150376	0.43062187255338247
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.43062187255338247
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00150376	0.43062187255338247
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00150376	0.43062187255338247
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.43062187255338247
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00150376	0.43062187255338247
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00150376	0.43062187255338247
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.43062187255338247
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00150376	0.43062187255338247
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.43062187255338247
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.43062187255338247
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00150376	0.43062187255338247
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00150376	0.43062187255338247
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00150376	0.43062187255338247
COG5-CDG	0.00150376	0.43062187255338247
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00150376	0.43062187255338247
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.43062187255338247
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00150376	0.43062187255338247
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.43062187255338247
KEIPERT SYNDROME	0.00150376	0.43062187255338247
NATHALIE SYNDROME	0.00150376	0.43062187255338247
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00150376	0.43062187255338247
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00150376	0.43062187255338247
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.43062187255338247
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.43062187255338247
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.43062187255338247
OCULOFACIOCARDIODENTAL SYNDROME	0.00150376	0.43062187255338247
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00150376	0.43062187255338247
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00150376	0.43062187255338247
IMMUNODEFICIENCY 47	0.00150376	0.43062187255338247
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00150376	0.43062187255338247
KEIPERT SYNDROME; KPTS	0.00150376	0.43062187255338247
COFFIN-LOWRY SYNDROME; CLS	0.00150376	0.43062187255338247
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.43062187255338247
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.43062187255338247
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, X-LINKED 1	0.00150376	0.43062187255338247
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00150376	0.43062187255338247
1Q21.1 MICRODELETION SYNDROME	0.00150376	0.43062187255338247
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.43062187255338247
6Q25 MICRODELETION SYNDROME	0.00150376	0.43062187255338247
ALPORT SYNDROME, X-LINKED; ATS	0.00150376	0.43062187255338247
19P13.12 MICRODELETION SYNDROME	0.00150376	0.43062187255338247
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00150376	0.43062187255338247
FABRY DISEASE	0.00150376	0.43062187255338247
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00150376	0.43062187255338247
MOYNAHAN SYNDROME	0.00150376	0.43062187255338247
MYOPATHY AND DIABETES MELLITUS	0.00150376	0.43062187255338247
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
OPITZ G/BBB SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, X-LINKED 4	0.00150376	0.43062187255338247
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.43062187255338247
DE SANCTIS-CACCHIONE SYNDROME	0.00150376	0.43062187255338247
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00150376	0.43062187255338247
ACROOTOOCULAR SYNDROME	0.00150376	0.43062187255338247
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.43062187255338247
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00150376	0.43062187255338247
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00150376	0.43062187255338247
SHORT SYNDROME	0.00150376	0.43062187255338247
ROTHMUND-THOMSON SYNDROME	0.00150376	0.43062187255338247
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.43062187255338247
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.43062187255338247
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.43062187255338247
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 3B	0.00150376	0.43062187255338247
REFSUM DISEASE	0.00150376	0.43062187255338247
SCLEROSTEOSIS	0.00150376	0.43062187255338247
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00150376	0.43062187255338247
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.43062187255338247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00150376	0.43062187255338247
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.43062187255338247
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.43062187255338247
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.00150376	0.43062187255338247
CHANARIN-DORFMAN SYNDROME	0.00150376	0.43062187255338247
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00150376	0.43062187255338247
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00150376	0.43062187255338247
LATERAL MENINGOCELE SYNDROME	0.00150376	0.43062187255338247
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.43062187255338247
WAARDENBURG-SHAH SYNDROME	0.00150376	0.43062187255338247
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00150376	0.43062187255338247
USHER SYNDROME, TYPE IIIA	0.00150376	0.43062187255338247
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
CONGENITAL RUBELLA SYNDROME	0.00150376	0.43062187255338247
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
STIFF SKIN SYNDROME	0.00150376	0.43062187255338247
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00150376	0.43062187255338247
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.43062187255338247
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.43062187255338247
THYROCEREBRORETINAL SYNDROME	0.00150376	0.43062187255338247
LAURENCE-MOON SYNDROME	0.00150376	0.43062187255338247
COWCHOCK SYNDROME; COWCK	0.00150376	0.43062187255338247
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00150376	0.43062187255338247
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00150376	0.43062187255338247
AMISH INFANTILE EPILEPSY SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.43062187255338247
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.43062187255338247
CDAGS SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.43062187255338247
MYH9-RELATED DISEASE	0.00150376	0.43062187255338247
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00150376	0.43062187255338247
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.43062187255338247
MUENKE SYNDROME	0.00150376	0.43062187255338247
SEVERE COMBINED IMMUNODEFICIENCY	0.00150376	0.43062187255338247
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.43062187255338247
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338247
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.43062187255338247
EEC SYNDROME	0.00150376	0.43062187255338247
COCKAYNE SYNDROME	0.00150376	0.43062187255338247
FETAL IODINE SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00150376	0.43062187255338247
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.43062187255338247
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.43062187255338247
USHER SYNDROME, TYPE IG	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.43062187255338247
1P36 DELETION SYNDROME	0.00150376	0.43062187255338247
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.43062187255338247
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00150376	0.43062187255338247
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00150376	0.43062187255338247
SPONDYLOOCULAR SYNDROME; SOS	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.43062187255338247
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00150376	0.43062187255338247
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.43062187255338247
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.43062187255338247
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00150376	0.43062187255338247
STICKLER SYNDROME, TYPE II	0.00150376	0.43062187255338247
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.43062187255338247
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.43062187255338247
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00150376	0.43062187255338247
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.43062187255338247
DONNAI-BARROW SYNDROME	0.00150376	0.43062187255338247
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.43062187255338247
HYPERTRYPTOPHANEMIA; HYPTRP	0.00150376	0.43062187255338247
CHROMOSOME 2Q37 DELETION SYNDROME	0.00150376	0.43062187255338247
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.43062187255338247
CODAS SYNDROME	0.00150376	0.43062187255338247
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00150376	0.43062187255338247
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.43062187255338247
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.43062187255338247
8Q12 MICRODUPLICATION SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.43062187255338247
DEAFNESS, Y-LINKED 1	0.00150376	0.43062187255338247
USHER SYNDROME TYPE 1	0.00150376	0.43062187255338247
USHER SYNDROME TYPE 2	0.00150376	0.43062187255338247
USHER SYNDROME TYPE 3	0.00150376	0.43062187255338247
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.43062187255338247
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.43062187255338247
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.43062187255338247
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00150376	0.43062187255338247
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.43062187255338247
CHROMOSOME 18Q DELETION SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.43062187255338247
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00150376	0.43062187255338247
CORNELIA DE LANGE SYNDROME	0.00150376	0.43062187255338247
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00150376	0.43062187255338247
EAST SYNDROME	0.00150376	0.43062187255338247
CRANDALL SYNDROME	0.00150376	0.43062187255338247
BRAIN-LUNG-THYROID SYNDROME	0.00150376	0.43062187255338247
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00150376	0.43062187255338247
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.43062187255338247
GEMIGNANI SYNDROME	0.00150376	0.43062187255338247
AYME-GRIPP SYNDROME; AYGRP	0.00150376	0.43062187255338247
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.43062187255338247
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.43062187255338247
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.43062187255338247
